aromatase inhibitors

Extending Endocrine Treatment Duration for Early Breast Cancer

This article reviews a patient-level meta-analysis on prolonging endocrine therapy for early breast cancer in postmenopausal women, focusing on the benefits of additional aromatase inhibitor treatment after five years of initial therapy.

Inconsistent Bone Health Management in Older Women With Breast Cancer: Insights From the Age Gap Study